Crewe Advisors LLC Baxter International Inc Transaction History

Crewe Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$39.98 - $47.68 $14,272 - $17,021	-357 Reduced 54.5%	298 $13,000
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $187 - $262	-5 Reduced 0.76%	655 $26,000
Q4 2022 Feb 07, 2023	SELL	$49.7 - $57.71 $9,592 - $11,138	-193 Reduced 22.63%	660 $33,000
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $35,439 - $43,954	-658 Reduced 43.55%	853 $46,000
Q2 2022 Aug 02, 2022	BUY	$63.83 - $80.0 $20,170 - $25,280	316 Added 26.44%	1,511 $97,000
Q1 2022 Apr 27, 2022	BUY	$76.85 - $89.45 $66,475 - $77,374	865 Added 262.12%	1,195 $92,000
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $24,608 - $28,772	330 New	330 $28,000
Q4 2020 Jan 27, 2021	SELL	$75.39 - $82.36 $2,110 - $2,306	-28 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$78.33 - $90.73 $2,193 - $2,540	28 New	28 $2,000
Q3 2019 Nov 06, 2019	SELL	$81.4 - $89.78 $8,954 - $9,875	-110 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$73.44 - $82.41 $8,078 - $9,065	110 New	110 $9,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.